VIENNA, Va., Oct. 31 /PRNewswire-FirstCall/ -- Modigene Inc. (OTC Bulletin Board: MODG) today announced that senior management will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on Wednesday, November 7, 2007 at 1:40 pm ET. The conference will be held at the New York Palace Hotel in New York City.
Modigene CEO Abraham Havron and President Shai Novik will attend. Management will provide a company overview and review of corporate developments.
The presentation will be webcast live and can be accessed by visiting the Investors section of the Modigene website at http://www.modigeneinc.com. An archived version of the webcast will be available for approximately 90 days. The live and archived webcast can also be accessed at http://www.wsw.com/webcast/rrshq12/modg.ob.
For more information about this conference, visit: http://www.rodmanandrenshaw.com/conferences?id=6
Modigene Inc. is a biopharmaceutical company applying its patented CTP technology to develop longer-acting, proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales. The CTP technology is applicable to virtually all proteins and Modigene is currently developing long-acting versions of human growth hormone, interferon beta and erythropoietin, which are in late preclinical development, as well as GLP-1. For more information on Modigene, visit http://www.modigeneinc.com.
MODIGENE CONTACT: MEDIA CONTACT:
Shai Novik, President Barbara Lindheim
Modigene Inc. GendeLLindheim BioCom Partners
Tel: +1 866 644-7811 +1 212 918-4650
|SOURCE Modigene Inc.|
Copyright©2007 PR Newswire.
All rights reserved